Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Ana Muniz-Lozano"'
Autor:
Jung Rae Cho, Francesco Franchi, Fabiana Rollini, Martin M. Zenni, Ronakkumar Patel, Antonio Tello-Montoliu, Dominick J. Angiolillo, Jose-Luis Ferreiro, Bhaloo Desai, Luis A. Guzman, Theodore A. Bass, Andrew Darlington, Ana Muniz-Lozano, Elisabetta Ferrante, Mona Bhatti, Christopher DeGroat
Publikováno v:
Journal of Cardiovascular Translational Research. 7:53-63
Smokers have a greater relative benefit of clopidogrel therapy compared with nonsmokers, likely attributed to its enhanced pharmacodynamic (PD) effects. However, to date, all PD studies have been conducted in patients on dual antiplatelet therapy wit
Publikováno v:
Expert Review of Cardiovascular Therapy. 11:1279-1291
Dual antiplatelet therapy with aspirin and an oral ADP P2Y12 receptor antagonist is the standard-of-care for the prevention of ischemic events in patients with acute coronary syndrome or undergoing percutaneous coronary intervention (PCI). However, c
Autor:
Bhaloo Desai, Ana Muniz-Lozano, Andrew Darlington, Norbert Bender, Ryan E. Wilson, Kjell S. Sakariassen, Ronakkumar Patel, Fabiana Rollini, Francesco Franchi, Dominick J. Angiolillo, Antonio Tello-Montoliu
Publikováno v:
Journal of Thrombosis and Thrombolysis. 37:131-138
Patients with diabetes mellitus (DM) have increased propensity to generate thromboxane A2 (TXA2) and other eicosanoids which can contribute to their heightened platelet reactivity. EV-077 is a potent thromboxane receptor antagonist and thromboxane sy
Autor:
Ana Muniz-Lozano, Francesco Franchi, Andrew Darlington, Luis A. Guzman, Fabiana Rollini, Bhaloo Desai, Dominick J. Angiolillo, Estela Thano, Ryan E. Wilson, Theodore A. Bass, Ronakkumar Patel, Antonio Tello-Montoliu
Publikováno v:
Thrombosis and Haemostasis. 110:777-784
SummaryDifferent aspirin dosing regimens have been suggested to impact outcomes when used in combination with adenosine diphosphate (ADP) P2Y12 receptor antagonists. Prior investigations have shown that not only aspirin, but also potent ADP P2Y12 rec
Autor:
Kamaldeep Singh, Elizabeth C Dunn, Jung Rae Cho, Mona Bhatti, Theodore A. Bass, Martin M. Zenni, Elisabetta Ferrante, Luis A. Guzman, Ana Muniz-Lozano, Christopher DeGroat, Francesco Franchi, Ryan E. Wilson, Dominick J. Angiolillo, Fabiana Rollini
Publikováno v:
European heart journal. 37(35)
Pharmacodynamic (PD) studies comparing prasugrel and ticagrelor have reached inconsistent findings. Therefore, a comprehensive investigation comparing the PD effects of prasugrel vs. ticagrelor after switching from clopidogrel therapy, exploring both
Autor:
Jung Rae, Cho, Fabiana, Rollini, Francesco, Franchi, Christopher, DeGroat, Mona, Bhatti, Elizabeth C, Dunn, Elisabetta, Ferrante, Ana, Muniz-Lozano, Siva, Suryadevara, Martin M, Zenni, Luis A, Guzman, Theodore A, Bass, Dominick J, Angiolillo
Publikováno v:
JACC. Cardiovascular interventions. 8(8)
The aim of this study was to assess the impact of ticagrelor dosing regimens on pharmacodynamic (PD) profiles in patients on maintenance ticagrelor therapy.Many patients on maintenance P2Y12-inhibiting therapies may require coronary revascularization
Autor:
Fabiana Rollini, Jung Rae Cho, Francesco Franchi, Mona Bhatti, Christopher DeGroat, Mohamad Taha, Ana Muniz-Lozano, Kamaldeep Singh, Elisabetta Ferrante, Elizabeth C Dunn, Martin M Zenni, Luis A Guzman, Theodore A Bass, Dominick J Angiolillo
Publikováno v:
Circulation. 130
Background: Clopidogrel is characterized by non-uniform pharmacodynamic (PD) effects leading to considerable rates of high on-treatment platelet reactivity (HPR), a marker of increased atherothrombotic risk. Prasugrel and ticagrelor have greater pote
Autor:
Mona Bhatti, Jung Rae Cho, Luis A. Guzman, Fabiana Rollini, Michael J. Haas, Ana Muniz-Lozano, Antonio Tello-Montoliu, Bhaloo Desai, Theodore A. Bass, Elisabetta Ferrante, Dominick J. Angiolillo, Christopher DeGroat, Francesco Franchi
Publikováno v:
Journal of the American College of Cardiology. 63(12)
Publikováno v:
Management of Cardiovascular Disease in Women ISBN: 9781447155164
Despite the numerous randomized trials that have evaluated the use of antithrombotic therapy in the setting of acute coronary syndromes (ACS) and atrial fibrillation (AF), the heterogeneity of the population enrolled in the majority of these studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb41dfdeb4a17572820425958fc4444e
https://doi.org/10.1007/978-1-4471-5517-1_15
https://doi.org/10.1007/978-1-4471-5517-1_15
Autor:
Jung Rae Cho, Antonio Tello-Montoliu, Bhaloo Desai, Francesco Franchi, Elisabetta Ferrante, Dominick J. Angiolillo, Fabiana Rollini, Theodore A. Bass, Luis A. Guzman, Ana Muniz-Lozano, Michael J. Haas
Publikováno v:
Journal of cardiovascular translational research. 7(1)
Smoking enhances the P2Y12 receptor inhibitory effects of clopidogrel. Nicotine increases P2Y12 receptor expression in platelet lysates from healthy volunteers. However, the impact of cigarette smoking on platelet P2Y12 receptor binding in clopidogre